Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| SI-BONE, Inc.SIBN · Entity 2501 | Chief Op & Financial Officer | October 02, 2026 | October 06, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
SI-BONE, Inc.
Report date October 02, 2026 · Filed October 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 221,724 |
Reported balance
After 2026-10-02 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-10-02 · Sale · Disposed 1,560 · Balance 221,724 F1: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2: This transaction was executed in multiple trades at prices ranging from $18.05 USD to $18.45 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| Common StockSEC Table I · non-derivative | Direct | 219,966 |
Reported balance
After 2026-10-02 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2026-10-02 · Sale · Disposed 1,758 · Balance 219,966 F1: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2: This transaction was executed in multiple trades at prices ranging from $18.05 USD to $18.45 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| Common StockSEC Table I · non-derivative | Direct | 218,235 |
Reported balance
After 2026-10-05 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2026-10-05 · Sale · Disposed 1,731 · Balance 218,235 F3: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan dated December 17, 2025. F4: Includes 160,823 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
F2: This transaction was executed in multiple trades at prices ranging from $18.05 USD to $18.45 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan dated December 17, 2025.
F4: Includes 160,823 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 06, 2023 Filed Jan 9, 2023 23:47 UTC | SI-BONE, Inc. SIBN · Entity 2501 | GrantCommon Stock | 19,159 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-000310 · primarydocument.xml · nonDerivative · entry 2 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,124 F2 · shares: Reflects shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The shares subject to the restricted stock unit will vest, if at all, over three years based on the Issuer's total shareholder return (TSR) as measured against the TSR of the company at the median of the range TSRs of a set of peer companies established by the Issuer as set forth in the grant. F3 · balance_after: Includes 148,435 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 06, 2023 Filed Jan 9, 2023 23:47 UTC | SI-BONE, Inc. SIBN · Entity 2501 | GrantCommon Stock | 57,478 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-000310 · primarydocument.xml · nonDerivative · entry 1 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,965 F1 · shares: Reflects shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The shares subject to the restricted stock unit will vest over four years beginning on January 1, 2023, and will be released in quarterly installments, subject to the Reporting Person's continued service through each relevant vesting date. Read SEC document |
| August 16, 2022 Filed Aug 17, 2022 22:27 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 882 | $17.29 | $15,247.31 |
DisclosureSEC source: 0001562180-22-006192 · primarydocument.xml · nonDerivative · entry 2 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,487 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · balance_after: Includes 76,801 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| August 16, 2022 Filed Aug 17, 2022 22:27 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 827 | $17.29 | $14,296.51 |
DisclosureSEC source: 0001562180-22-006192 · primarydocument.xml · nonDerivative · entry 1 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,369 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| May 16, 2022 Filed May 18, 2022 00:57 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 883 | $12.58 | $11,108.76 |
DisclosureSEC source: 0001562180-22-004169 · primarydocument.xml · nonDerivative · entry 2 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,196 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · balance_after: Includes 81,803 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F3 · balance_after: Includes 1,331 shares acquired under the SI-BONE, Inc. 2018 Employee Stock Purchase Plan on May 15, 2022. Read SEC document |
| May 16, 2022 Filed May 18, 2022 00:57 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 3,228 | $12.58 | $40,610.50 |
DisclosureSEC source: 0001562180-22-004169 · primarydocument.xml · nonDerivative · entry 1 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,748 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| January 06, 2022 Filed Jan 10, 2022 20:07 UTC | SI-BONE, Inc. SIBN · Entity 2501 | GrantCommon Stock | 13,934 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-000364 · primarydocument.xml · nonDerivative · entry 2 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,976 F2 · shares: Reflects shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted unit represents a contingent right to receive one share of the Issuer's common stock. The shares are subjected to the restricted stock unit vest, if at all, over three years based on the Issuer's total shareholder return (TSR) as measured against the TSR of the company at the median of the range TSRs of a set of peer companies established by the Issuer as set forth in the grant. F3 · balance_after: Includes 93,976 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 06, 2022 Filed Jan 10, 2022 20:07 UTC | SI-BONE, Inc. SIBN · Entity 2501 | GrantCommon Stock | 41,802 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-000364 · primarydocument.xml · nonDerivative · entry 1 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,042 F1 · shares: Reflects shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The shares subject to the restricted stock unit will vest over four years beginning on January 1, 2022, and will be released in quarterly installments commencing on May 15, 2022, subject to the Reporting Person's continued service through each relevant vesting date. Read SEC document |
| April 20, 2021 Filed Apr 21, 2021 22:24 UTC | SI-BONE, Inc. SIBN · Entity 2501 | GrantCommon Stock | 38,240 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-002902 · primarydocument.xml · nonDerivative · entry 1 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,240 F1 · shares: Reflects shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. 25% of the shares shall vest and be released on the one-year anniversary of the Vesting Commencement Date; thereafter, the remaining 75% of the shares vest in a series of twelve equal quarterly installments, each equal to 6.25% of the award shares, until the award is fully vested on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each relevant vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.